J Lawrance Selected Research

CDP860

2/2005

Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volume.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Lawrance Research Topics

Disease

2	Neoplasms (Cancer) 12/2007 - 02/2005
1	Acromegaly 07/2009
1	Hypertension (High Blood Pressure) 12/2007
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2005
1	Colorectal Neoplasms (Colorectal Cancer) 02/2005
1	Anorexia 04/2003
1	Abdominal Pain (Pain, Abdominal) 04/2003

Drug/Important Bio-Agent (IBA)

1	pegvisomant FDA LinkGeneric 07/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2007
1	Pharmaceutical PreparationsIBA 12/2007
1	Interleukin-2 (IL2)IBA 10/2005
1	Histamine (Histamine Dihydrochloride)FDA Link 10/2005
1	CDP860IBA 02/2005
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 02/2005
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 02/2005
1	GP 4 (GP4)IBA 04/2003

Therapy/Procedure

1	Therapeutics 07/2009
1	Intravenous Infusions 02/2005